Alcoholic Hepatitis

References

1. • Crabb D.W.
   • Bataller R.
   • Chalasani N.P.
   • et al.
   Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.
   Gastroenterology. 2016; 150: 785-790
   View in Article

   • Google Scholar
2. • Maddrey W.C.
   • Boitnott J.K.
   • Bedine M.S.
   • et al.
   Corticosteroid therapy of alcoholic hepatitis.
   Gastroenterology. 1978; 75: 193-199
   View in Article

   • Google Scholar
3. • Philips C.A.
   • Augustine P.
   • Yerol P.K.
   • et al.
   Severe alcoholic hepatitis: current perspectives.
   HMER. 2019; 11: 97-108
   View in Article

   • Google Scholar
4. • Basra S.
   Definition, epidemiology and magnitude of alcoholic hepatitis.
   WJH. 2011; 3: 108
   View in Article

   • Google Scholar
5. • Shirazi F.
   • Singal A.K.
   • Wong R.J.
   Alcohol-associated Cirrhosis and Alcoholic Hepatitis Hospitalization Trends in the United States.
   J Clin Gastroenterol. 2021; 55: 174-179
   View in Article

   • Google Scholar
6. • Hirode G.
   • Saab S.
   • Wong R.J.
   Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
   JAMA Netw Open. 2020; 3: e201997
   View in Article

   • Google Scholar
7. • Liangpunsakul S.
   Clinical Characteristics and Mortality of Hospitalized Alcoholic Hepatitis Patients in the United States.
   J Clin Gastroenterol. 2011; 45: 714-719
   View in Article

   • Google Scholar
8. • Mandayam S.
   • Jamal M.M.
   • Morgan T.R.
   Epidemiology of Alcoholic Liver Disease.
   Semin Liver Dis. 2004; 24: 217-232
   View in Article

   • Google Scholar
9. • Doycheva I.
   • Watt K.D.
   • Rifai G.
   • et al.
   Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
   Dig Dis Sci. 2017; 62: 1373-1380
   View in Article

   • Google Scholar
10. • Alkhouri N.
    • Almomani A.
    • Le P.
    • et al.
    The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
    BMC Gastroenterol. 2022; 22: 366
    View in Article

    • Google Scholar
11. • Tapper E.B.
    • Parikh N.D.
    Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.
    BMJ. 2018; 362: k2817
    View in Article

    • Google Scholar
12. • Yeo Y.H.
    • He X.
    • Ting P.S.
    • et al.
    Evaluation of Trends in Alcohol Use Disorder–Related Mortality in the US Before and During the COVID-19 Pandemic.
    JAMA Netw Open. 2022; 5: e2210259
    View in Article

    • Google Scholar
13. • White A.M.
    • Castle I.J.P.
    • Powell P.A.
    • et al.
    Alcohol-Related Deaths During the COVID-19 Pandemic.
    JAMA. 2022; 327: 1704-1706
    View in Article

    • Google Scholar
14. • Sharma R.A.
    • Subedi K.
    • Gbadebo B.M.
    • et al.
    Alcohol Withdrawal Rates in Hospitalized Patients During the COVID-19 Pandemic.
    JAMA Netw Open. 2021; 4: e210422
    View in Article

    • Google Scholar
15. • Barbosa C.
    • Cowell A.J.
    • Dowd W.N.
    Alcohol Consumption in Response to the COVID-19 Pandemic in the United States.
    J Addict Med. 2021; 15: 341-344
    View in Article

    • Google Scholar
16. • Julien J.
    • Ayer T.
    • Tapper E.B.
    • et al.
    Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study.
    Hepatology. 2022; 75: 1480-1490
    View in Article

    • Google Scholar
17. • Deutsch-Link S.
    • Jiang Y.
    • Peery A.F.
    • et al.
    Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic.
    Clin Gastroenterol Hepatol. 2022; 20 (e2): 2142-2144
    View in Article

    • Google Scholar
18. • Sohal A.
    • Khalid S.
    • Green V.
    • et al.
    The Pandemic Within the Pandemic.
    J Clin Gastroenterol. 2022; 56: e171-e175
    View in Article

    • Google Scholar
19. • Damjanovska S.
    • Karb D.B.
    • Cohen S.M.
    Increasing Prevalence and Racial Disparity of Alcohol-Related Gastrointestinal and Liver Disease During the COVID-19 Pandemic: A Population-Based National Study.
    J Clin Gastroenterol. 2022; (Publish Ahead of Print)
    View in Article

    • Google Scholar
20. • Gonzalez H.C.
    • Zhou Y.
    • Nimri F.M.
    • et al.
    Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA.
    Liver Int. 2022; 42: 762-764
    View in Article

    • Google Scholar
21. • Shaheen A.A.
    • Kong K.
    • Ma C.
    • et al.
    Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada.
    Clin Gastroenterol Hepatol. 2022; 20: e1170-e1179
    View in Article

    • Google Scholar
22. • Marlowe N.
    • Lam D.
    • Krebs W.
    • et al.
    Prevalence, co-morbidities, and in-hospital mortality of patients hospitalized with alcohol-associated hepatitis in the United States from 2015 to 2019.
    Alcohol Clin Exp Res. 2022; 46: 1472-1481
    View in Article

    • Google Scholar
23. • Dhanda A.D.
    Is liver biopsy necessary in the management of alcoholic hepatitis?.
    WJG. 2013; 19: 7825
    View in Article

    • Google Scholar
24. • Arab J.P.
    • Díaz L.A.
    • Baeza N.
    • et al.
    Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.
    J Hepatol. 2021; 75: 1026-1033
    View in Article

    • Google Scholar
25. • Rahimi E.
    • Pan J.J.
    Prognostic models for alcoholic hepatitis.
    Biomark Res. 2015; 3: 20
    View in Article

    • Google Scholar
26. • Dominguez M.
    • Rincón D.
    • Abraldes J.G.
    • et al.
    A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis.
    Am J Gastroenterol. 2008; 103: 2747-2756https://doi.org/10.1111/j.1572-0241.2008.02104.x
    View in Article

    • Google Scholar
27. • Morales-Arráez D.
    • Ventura-Cots M.
    • Altamirano J.
    • et al.
    The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Am J Gastroenterol. 2022; 117: 301-310
    View in Article

    • Google Scholar
28. • Louvet A.
    • Naveau S.
    • Abdelnour M.
    • et al.
    The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
    Hepatology. 2007; 45: 1348-1354
    View in Article

    • Google Scholar
29. • Mathurin P.
    • O’Grady J.
    • Carithers R.L.
    • et al.
    Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.
    Gut. 2011; 60: 255-260
    View in Article

    • Google Scholar
30. • Garcia-Saenz-de-Sicilia M.
    • Duvoor C.
    • Altamirano J.
    • et al.
    A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2017; 112: 306-315
    View in Article

    • Google Scholar
31. • Louvet A.
    • Labreuche J.
    • Artru F.
    • et al.
    Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.
    Gastroenterology. 2015; 149 (e8): 398-406
    View in Article

    • Google Scholar
32. • Kulkarni K.
    • Tran T.
    • Medrano M.
    • et al.
    The Role of the Discriminant Factor in the Assessment and Treatment of Alcoholic Hepatitis.
    J Clin Gastroenterol. 2004; 38: 453-459
    View in Article

    • Google Scholar
33. • Hanouneh I.A.
    • Zein N.N.
    • Cikach F.
    • et al.
    The Breathprints in Patients with Liver Disease Identify Novel Breath Biomarkers in Alcoholic Hepatitis.
    Clin Gastroenterol Hepatol. 2014; 12: 516-523
    View in Article

    • Google Scholar
34. • Bissonnette J.
    • Altamirano J.
    • Devue C.
    • et al.
    A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.
    Hepatology. 2017; 66: 555-563
    View in Article

    • Google Scholar
35. • Momen-Heravi F.
    • Saha B.
    • Kodys K.
    • et al.
    Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    J Transl Med. 2015; 13: 261
    View in Article

    • Google Scholar
36. • Atkinson S.R.
    • Grove J.I.
    • Liebig S.
    • et al.
    In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.
    ACG. 2020; 115: 1857-1868
    View in Article

    • Google Scholar
37. • Brandl K.
    • Hartmann P.
    • Jih L.J.
    • et al.
    Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis.
    J Hepatol. 2018; 69: 396-405
    View in Article

    • Google Scholar
38. • Sandahl T.D.
    • Grønbæk H.
    • Møller H.J.
    • et al.
    Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study.
    Am J Gastroenterol. 2014; 109: 1749-1756
    View in Article

    • Google Scholar
39. • Michelena J.
    • Altamirano J.
    • Abraldes J.G.
    • et al.
    Systemic Inflammatory Response and Serum Lipopolysaccharide Levels Predict Multiple Organ Failure and Death in Alcoholic Hepatitis.
    Hepatology. 2015; 62: 762-772
    View in Article

    • Google Scholar
40. • Gala K.S.
    • Vatsalya V.
    Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.
    Cells. 2020; 9: 524
    View in Article

    • Google Scholar
41. • Cabré E.
    • Rodríguez-Iglesias P.
    • Caballería J.
    • et al.
    Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial.
    Hepatology. 2000; 32: 36-42
    View in Article

    • Google Scholar
42. • Moreno C.
    • Deltenre P.
    • Senterre C.
    • et al.
    Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.
    Gastroenterology. 2016; 150 (e8): 903-910
    View in Article

    • Google Scholar
43. • Singal A.K.
    • Bataller R.
    • Ahn J.
    • et al.
    ACG Clinical Guideline: Alcoholic Liver Disease.
    Am J Gastroenterol. 2018; 113: 175-194
    View in Article

    • Google Scholar
44. • Crabb D.W.
    • Im G.Y.
    • Szabo G.
    • et al.
    Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.
    Hepatology. 2020; 71: 306-333
    View in Article

    • Google Scholar
45. • Thursz M.
    • Gual A.
    • Lackner C.
    • et al.
    EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.
    J Hepatol. 2018; 69: 154-181
    View in Article

    • Google Scholar
46. • Singal A.K.
    • Walia I.
    • Singal A.
    • et al.
    Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current status.
    World J Hepatol. 2011; 3: 205-210
    View in Article

    • Google Scholar
47. • Thursz M.R.
    • Richardson P.
    • Allison M.
    • et al.
    Prednisolone or Pentoxifylline for Alcoholic Hepatitis.
    N Engl J Med. 2015; 372: 1619-1628
    View in Article

    • Google Scholar
48. • Louvet A.
    • Thursz M.R.
    • Kim D.J.
    • et al.
    Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo—a Meta-analysis of Individual Data From Controlled Trials.
    Gastroenterology. 2018; 155 (e8): 458-468
    View in Article

    • Google Scholar
49. • Louvet A.
    • Wartel F.
    • Castel H.
    • et al.
    Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
    Gastroenterology. 2009; 137: 541-548
    View in Article

    • Google Scholar
50. • Philippe M.
    • Christophe M.
    • Didier S.
    • et al.
    Early Liver Transplantation for Severe Alcoholic Hepatitis.
    N Engl J Med. 2011; 365: 1790-1800
    View in Article

    • Google Scholar
51. • Raff E.
    • Singal A.K.
    Optimal management of alcoholic hepatitis.
    Minerva Gastroenterol Dietol. 2014; 60: 15
    View in Article

    • Google Scholar
52. • Singal A.K.
    • Salameh H.
    • Singal A.
    • et al.
    Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians.
    World J Gastrointest Pharmacol Ther. 2013; 4: 16-22
    View in Article

    • Google Scholar
53. • Akriviadis E.
    • Botla R.
    • Briggs W.
    • et al.
    Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial.
    Gastroenterology. 2000; 119: 1637-1648
    View in Article

    • Google Scholar
54. • Singh S.
    • Murad M.H.
    • Chandar A.K.
    • et al.
    Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.
    Gastroenterology. 2015; 149 (e12): 958-970
    View in Article

    • Google Scholar
55. • Thompson J.
    • Jones N.
    • Al-Khafaji A.
    • et al.
    Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial.
    Liver Transpl. 2018; 24: 380-393
    View in Article

    • Google Scholar
56. • Singal A.K.
    • Shah V.H.
    Current trials and novel therapeutic targets for alcoholic hepatitis.
    J Hepatol. 2019; 70: 305-313
    View in Article

    • Google Scholar
57. • Thanda Han M.A.
    • Pyrsopoulos N.
    Emerging Therapies for Alcoholic Hepatitis.
    Clin Liver Dis. 2021; 25: 603-624
    View in Article

    • Google Scholar
58. • Purohit V.
    • Bode J.C.
    • Bode C.
    • et al.
    Alcohol, Intestinal Bacterial Growth, Intestinal Permeability to Endotoxin, and Medical Consequences.
    Alcohol. 2008; 42: 349-361
    View in Article

    • Google Scholar
59. • Philips C.A.
    • Pande A.
    • Shasthry S.M.
    • et al.
    Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study.
    Clin Gastroenterol Hepatol. 2017; 15: 600-602
    View in Article

    • Google Scholar
60. • Bajaj J.S.
    • Gavis E.A.
    • Fagan A.
    • et al.
    A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder.
    Hepatology. 2021; 73: 1688-1700
    View in Article

    • Google Scholar
61. • Philips C.A.
    • Ahamed R.
    • Rajesh S.
    • et al.
    Long-term Outcomes of Stool Transplant in Alcohol-associated Hepatitis—Analysis of Clinical Outcomes, Relapse, Gut Microbiota and Comparisons with Standard Care.
    J Clin Exp Hepatol. 2022; 12: 1124-1132
    View in Article

    • Google Scholar
62. • Szabo G.
    • Mitchell M.
    • McClain C.J.
    • et al.
    IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
    Hepatology. 2022; 76: 1058-1068
    View in Article

    • Google Scholar

63. Gawrieh S, Dasarathy S, Tu W, et al. Anakinra plus Zinc versus Prednisone for Treatment of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial. Poster presented at: The Liver Meeting. November 4-8, 2012; Washington D.C.

    View in Article

    • Google Scholar
64. • Hassanein T.
    • Stein L.
    • Flamm S.
    Safety and Efficacy of DUR-928: A Potential New Therapy for Acute Alcoholic Hepatitis.
    Hepatology. 2019; 70: 1483A-1484A
    View in Article

    • Google Scholar
65. • Nguyen-Khac E.
    • Thevenot T.
    • Piquet M.A.
    • et al.
    Glucocorticoids plus N -Acetylcysteine in Severe Alcoholic Hepatitis.
    N Engl J Med. 2011; 365: 1781-1789
    View in Article

    • Google Scholar
66. • Higuera-de la Tijera F.
    • Servín-Caamaño A.I.
    • Serralde-Zúñiga A.E.
    • et al.
    Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis.
    World J Gastroenterol. 2015; 21: 4975-4985
    View in Article

    • Google Scholar
67. • Brand S.
    • Dambacher J.
    • Beigel F.
    • et al.
    IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
    Am J Physiology-Gastrointestinal Liver Physiol. 2007; 292: G1019-G1028
    View in Article

    • Google Scholar
68. • Arab J.P.
    • Sehrawat T.S.
    • Simonetto D.A.
    • et al.
    An open label, dose escalation study to assess the safety and efficacy of il-22 agonist f-652 in patients with alcoholic hepatitis.
    Hepatology. 2020; 72: 441-453
    View in Article

    • Google Scholar
69. • Marot A.
    • Singal A.K.
    • Moreno C.
    • et al.
    Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials.
    JHEP Rep. 2020; 2: 100139
    View in Article

    • Google Scholar
70. • Lucey M.R.
    • Brown K.A.
    • Everson G.T.
    • et al.
    Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
    Liver Transplant Surg. 1997; 3: 628-637
    View in Article

    • Google Scholar
71. • Everhart J.E.
    • Beresford T.P.
    Liver transplantation for alcoholic liver disease: A survey of transplantation programs in the United States.
    Liver Transplant Surg. 1997; 3: 220-226
    View in Article

    • Google Scholar
72. • Jauhar S.
    • Talwalkar J.A.
    • Schneekloth T.
    • et al.
    Analysis of factors that predict alcohol relapse following liver transplantation.
    Liver Transplant. 2004; 10: 408-411
    View in Article

    • Google Scholar
73. Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease?.
    (Available at:)
    https://onlinelibrary.wiley.com
    doi:10.1111/j.1432-2277.2005.00208.x
    (Accessed November 20, 2022)
    View in Article

    • Google Scholar
74. • Mccallum S.
    • Masterton G.
    Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria.
    Alcohol Alcohol. 2006; 41: 358-363
    View in Article

    • Google Scholar
75. • Lim J.
    • Curry M.P.
    • Sundaram V.
    Risk factors and outcomes associated with alcohol relapse after liver transplantation.
    World J Hepatol. 2017; 9: 771-780
    View in Article

    • Google Scholar
76. • Lee B.P.
    • Mehta N.
    • Platt L.
    • et al.
    Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2018; 155: 422-430.e1
    View in Article

    • Google Scholar
77. • Lee B.P.
    • Chen P.H.
    • Haugen C.
    • et al.
    Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis.
    Ann Surg. 2017; 265: 20-29
    View in Article

    • Google Scholar
78. • Carrique L.
    • Quance J.
    • Tan A.
    • et al.
    Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment With Low Rate of Relapse.
    Gastroenterology. 2021; 161 (e2): 1896-1906
    View in Article

    • Google Scholar
79. • Herrick-Reynolds K.M.
    • Punchhi G.
    • Greenberg R.S.
    • et al.
    Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.
    JAMA Surg. 2021; 156: 1026-1034
    View in Article

    • Google Scholar
80. • Marot A.
    • Dubois M.
    • Trépo E.
    • et al.
    Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis.
    PLoS One. 2018; 13: e0190823
    View in Article

    • Google Scholar
81. • Mellinger J.L.
    • Volk M.L.
    Transplantation for Alcohol-related Liver Disease: Is It Fair?.
    Alcohol Alcohol. 2018; 53: 173-177
    View in Article

    • Google Scholar
82. • Glannon W.
    Responsibility and Priority in Liver Transplantation.
    Camb Q Healthc Ethics. 2009; 18: 23-35
    View in Article

    • Google Scholar
83. • Bangaru S.
    • Pedersen M.R.
    • MacConmara M.P.
    • et al.
    Survey of Liver Transplantation Practices for Severe Acute Alcoholic Hepatitis: Survey of Liver Transplantation.
    Liver Transpl. 2018; 24: 1357-1362
    View in Article

    • Google Scholar
84. • Cotter T.G.
    • Sandıkçı B.
    • Paul S.
    • et al.
    Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency.
    Am J Transpl. 2021; 21: 1039-1055
    View in Article

    • Google Scholar
85. • Bittermann T.
    • Mahmud N.
    • Weinberg E.M.
    • et al.
    Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022; 106: 1401-1410
    View in Article

    • Google Scholar
86. • Altamirano J.
    • López-Pelayo H.
    • Michelena J.
    • et al.
    Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival: Altamirano, López-Pelayo, et al.
    Hepatology. 2017; 66: 1842-1853
    View in Article

    • Google Scholar
87. • Elfeki M.A.
    • Abdallah M.A.
    • Leggio L.
    • et al.
    Simultaneous management of alcohol use disorder and of liver disease: a systematic review and meta-analysis.
    J Addict Med. 2022; (Publish Ahead of Print)https://doi.org/10.1097/ADM.0000000000001084
    View in Article

    • Google Scholar
88. • Evans M.D.
    • Diaz J.
    • Adamusiak A.M.
    • et al.
    Predictors of Survival After Liver Transplantation in Patients With the Highest Acuity (MELD ≥40).
    Ann Surg. 2020; 272: 458-466
    View in Article

    • Google Scholar
89. • Louvet A
    • Labreuche J.
    • Artru F.
    • et al.
    Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study.
    Hepatology. 2017; 66: 1464-1473
    View in Article

    • Google Scholar
90. • Ayyala D
    • Bottyan T.
    • Tien C.
    • et al.
    Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease.
    Hepaol Commun. 2022; 6: 3433-3442
    View in Article

    • Google Scholar
91. • Yamini D.
    • Lee S.H.
    • Avanesyan A.
    • et al.
    Utilization of Baclofen in Maintenance of Alcohol Abstinence in Patients with Alcohol Dependence and Alcoholic Hepatitis with or without Cirrhosis.
    Alcohol Alcohol. 2014; 49: 453-456
    View in Article

    • Google Scholar
92. • Reus V.I.
    • Hilty D.M.
    • Pasic J.
    • et al.
    The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder.
    Am J Psychiatry. 2018; 175: 86-90
    View in Article

    • Google Scholar
93. • Rogal S.
    • Youk A.
    • Zhang H.
    • et al.
    Impact of Alcohol Use Disorder Treatment on Clinical Outcomes among Patients with Cirrhosis.
    Hepatology. 2020; 71: 2080-2092
    View in Article

    • Google Scholar
94. • DiMartini A.F.
    • Leggio L.
    • Singal A.K.
    Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models.
    Lancet Gastroenterol Hepatol. 2022; 7: 186-195
    View in Article

    • Google Scholar
95. • Lucey M.R.
    • Singal A.K.
    Integrated Treatment of Alcohol Use Disorder in Patients With Alcohol-Associated Liver Disease: An Evolving Story.
    Hepatology. 2020; 71: 1891-1893
    View in Article

    • Google Scholar
96. • Mellinger J.L.
    • Scott Winder G.
    • DeJonckheere M.
    • et al.
    Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis.
    J Substance Abuse Treat. 2018; 91: 20-27
    View in Article

    • Google Scholar